| Financial Year |
March 31 2023 |
| Monetary Funds |
245,982,364.61 |
| Held-for-trading Financial Assets |
2,100,593.88 |
| Notes Receivable |
20,317,791.12 |
| Accounts Receivable |
294,337,753.69 |
| Advances to Suppliers |
16,417,700.07 |
| Other Receivables |
14,764,010.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
595,661,711.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,972,528.81 |
| Total Current Assets |
1,225,282,294.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
321,697,639.51 |
| Under-construction Projects |
543,719.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,812,442.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,182,991.64 |
| Deferred Income Tax Assets |
22,403,580.10 |
| Other Non-Current Assets |
1,559,051.00 |
| Sub-Total of Non-Current Assets |
397,212,650.22 |
| Total Assets |
1,622,494,944.90 |
| Short-Term Loans |
125,759,041.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,800,000.00 |
| Accounts Payable |
209,398,053.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,265,939.65 |
| Taxes Payable |
5,771,126.39 |
| Interest Payable |
-- |
| Dividend Payable |
3,500,000.00 |
| Other payables |
14,554,833.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
5,691,926.70 |
| Sub-Total of Current Liabilities |
499,987,455.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,499,942.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,899,178.28 |
| Total Liabilities |
505,886,633.34 |
| Paid-In Capital(Or Share Stock) |
364,718,544.00 |
| Capital Surplus |
395,807,172.37 |
| Surplus Reserve |
134,542,775.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
171,658,289.85 |
| Minority Stockholder's Interest |
49,412,741.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,067,195,570.23 |
| Owner's Equity（Stockholder's Equity） |
1,116,608,311.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,622,494,944.90 |
